Event Overview

In many clinical trials, we seek to identify a subgroup of patients in which an active treatment is most effective compared to a control. These high-efficacy subgroups support patient enrichment and can change the clinical development strategy for the program. However, common strategies for finding these patient subgroups regularly uncover overly complex subgroups that are impractical for driving future trials and generate excessive false positive groups that fail to replicate in future trials. SDC has developed and tested a novel strategy that identifies practical high-efficacy subgroups while controlling the Type 1 (false positive) error rate. Join this webinar to learn about SDC’s Constrained Search and Permutation Evaluation (CSPE) method for identifying these subgroups in clinical trials, and how it can help optimize your clinical development strategy. 

Key Learning Objectives

	•	What are high-efficacy subgroups in clinical trials and why they matter
	•	What current methods are used to identify them, and pitfalls thereof
	•	How SDC's method identifies practical high-efficacy subgroups
	•	How identifying these subgroups can optimize your clinical development strategy

Who Should Attend

Clinical trial professionals who seek to optimize their clinical development strategy

Can't Attend as Scheduled? 

All registrants will receive a link to view the presentation after the live event. Register now to view it on-demand later.